If you’ve ever hesitated to try weight loss medication because of needles, you’re not alone. Weekly injections like Wegovy and Mounjaro are incredibly effective – but for some, they’re simply not practical or desirable.

That’s why Foundayo (Orforglipron), a new GLP-1 weight loss pill FDA approved, is generating such a buzz. It offers all the benefits of injectable weight loss treatments -without the injection.

Foundayo Orforglipron: What We Know So Far

Expected in 2026, Foundayo Orforglipron weight loss pill is developed by Eli Lilly and has passed Phase 3 clinical trials. Like other GLP-1 medications, it helps to:

The big difference? It comes in tablet form.

For the millions of people who dislike injections or struggle with weekly routines, this could be a welcome alternative.

No Need to Wait -Start Losing Weight Now

Although Orforglipron isn’t on the market just yet, you can begin your weight loss journey today using trusted alternatives already available.

At MedCare Health Clinic, we offer private consultations and prescriptions for:

Both are ideal if you’re looking to start now, with the option to switch to Orforglipron once it becomes available.

What Makes MedCare Different?

When you choose MedCare, you’re choosing expert, friendly care. Our service includes:

We take the time to understand your needs and help you find the most effective path forward.

Don’t Wait to Feel Better in Your Body

Yes, Foundayo Orforglipron is exciting -but the path to a healthier you can start today. With safe, effective treatments available now through MedCare Health Clinic, there’s no need to put your progress on hold.

👉 Click here to learn more and book your consultation